Browse
Submit Data
Databases
API
Help

Dataset Information

20 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Allosteric Glutaminase Inhibitors Based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane Scaffold.

ABSTRACT: A series of allosteric kidney-type glutaminase (GLS) inhibitors were designed and synthesized using 1,4-di(5-amino-1,3,4-thiadiazol-2-yl)butane as a core scaffold. A variety of modified phenylacetyl groups were incorporated into the 5-amino group of the two thiadiazole rings in an attempt to facilitate additional binding interactions with the allosteric binding site of GLS. Among the newly synthesized compounds, 4-hydroxy-N-[5-[4-[5-[(2-phenylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]-1,3,4-thiadiazol-2-yl]-benzeneacetamide, 2m, potently inhibited GLS with an IC50 value of 70 nM, although it did not exhibit time-dependency as seen with CB-839. Antiproliferative effects of 2m on human breast cancer lines will be also presented in comparison with those observed with CB-839.

SUBMITTER: Zimmermann SC

PROVIDER: S-EPMC4868099 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

1,1'-(Butane-1,4-di-yl)diimidazolium dinitrate.

Project description:In the title compound, C(10)H(16)N(4) (2+)·2NO(3) (-), the organic cation is located around an inversion centre. The imidazolium ring forms a dihedral angle of 62.7 (3)° with the plane defined by the C atoms of the -(CH(2))(4)- aliphatic linker. Two anions bind to the cation via three-centre N-H⋯O hydrogen bonds and thus discrete hydrogen-bonded ion triples are formed. The nitrate is approximately coplanar with the imidazolium ring to which it binds.

| S-EPMC2915236 | biostudies-literature

1,4-Bis{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}butane.

Project description:In the centrosymmetric title compound, C(18)H(16)N(6)O(2)S(2), the 1,3,4-oxadiazole and the attached pyridinyl ring are twisted by 5.3?(3)°.

| S-EPMC3052088 | biostudies-literature

1,4-Bis[(5-phenyl-1,3,4-thia-diazol-2-yl)sulfan-yl]butane.

Project description:The asymmetric unit of the title compound, C(20)H(18)N(4)S(4), contains one half-mol-ecule situated on a twofold rotation axis, in which the thia-diazole and phenyl rings are twisted by 7.2?(3)°. In the crystal, weak inter-molecular C-H?? inter-actions link the mol-ecules into layers parallel to (103).

| S-EPMC3052050 | biostudies-literature

1,1'-(Butane-1,4-di-yl)dipyridinium dibromide dihydrate.

Project description:The organic cation in the title compound, C(14)H(18)N(2) (2+)·2Br(-)·2H(2)O, is situated on an inversion centre. The cations, anions and water mol-ecules are linked via O-H⋯Br, C-H⋯Br and C-H⋯O hydrogen bonds, and π-π stacking inter-actions between adjacent pyridine rings, with a centroid-centroid separation of 3.8518 (17) Å.

| S-EPMC2960452 | biostudies-literature

5,5'-Diphenyl-2,2'-[butane-1,4-diylbis(sulfanedi-yl)]bis-(1,3,4-oxadiazole).

Project description:The complete mol-ecule of the title compound, C(20)H(18)N(4)O(2)S(2), is generated by crystallographic inversion symmetry. The benzene ring is almost coplanar with the oxadiazole ring [dihedral angle = 7.2?(2)°].

| S-EPMC3009329 | biostudies-literature

2,2'-(Butane-1,4-di-yl)diisoquinolinium tetra-chloridozincate(II).

Project description:The crystal of the title compound, (C(22)H(22)N(2))[ZnCl(4)], consists of 2,2'-(butane-1,4-di-yl)diisoquinolinium organic cations and [ZnCl(4)](2-) complex anions. The cation is located across a twofold axis and the Zn(II) atom of the anion is located on the other twofold axis. The centroid-centroid distance between parallel pyridine rings of neighboring mol-ecules is 3.699 (3) Å, but the face-to-face separation of 3.601 (3) Å suggests there is no significant π-π stacking in the crystal structure.

| S-EPMC2959863 | biostudies-literature

3,3'-Diphenyl-1,1'-(butane-1,4-di-yl)dithio-urea.

Project description:The asymmetric unit of the title compound, C(18)H(22)N(4)S(2), contains one half-mol-ecule, the complete mol-ecule being generated by crystallographic inversion symmetry. The crystal structure features two inter-molecular N-H⋯S hydrogen-bonding inter-actions, the first generating an infinite chain along the b axis and the second an infinite chain along the a axis, together forming an inter-locking structure.

| S-EPMC3200795 | biostudies-literature

1,1'-(Butane-1,4-di-yl)bis-[2-(pyridin-2-yl)-1H-benzimidazole].

Project description:The complete mol-ecule of the title compound, C(28)H(24)N(6), is generated by inversion symmetry with the inversion centre located at the mid-point of the central C-C bond of the butanediyl unit. The benzimidazole and pyridine rings are almost coplanar, the dihedral angle between their mean planes being 6.86 (11)°.

| S-EPMC3344554 | biostudies-literature

5,5'-(Butane-1,4-di-yl)bis-(1H-tetra-zole) dihydrate.

Project description:The title compound, C(6)H(10)N(8)·2H(2)O, was prepared by the reaction of hexanedinitrile and sodium azide. The di-1H-tetra-zole mol-ecule lies on a crystallographic centre of inversion and is linked to the water mol-ecules by N-H?O and O-H?N hydrogen bonds, forming a two-dimensional supra-molecular structure in the crystal.

| S-EPMC3011479 | biostudies-literature

3,3'-(Butane-1,4-di-yl)diimidazole-1,1'-diium bis-(triiodide).

Project description:The cations and anions of the salt, C(10)H(16)N(4) (2+)·2I(3) (-), are linked by N-H⋯I hydrogen bonds and π-π stacking inter-actions(with interplanar distances of 3.575 and 3.528 Å) into a three-dimensional supra-molecular network. The asymmetric unit contains two anions and two half-cations; each cation is centrosymmetric.

| S-EPMC2962153 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data